🔒 ★ European Medicines Agency Pre-Authorisation Procedural Advice
Guidance on procedural advice for users of the centralised procedure by the European Medicines Agency.
High impact 20 min
Drug profile · INN
vic-
vic- is an FDA-listed pharmaceutical active ingredient.
NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — vic-
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.70
Quick answer
vic- is an FDA-listed pharmaceutical active ingredient.
Key facts
INN vic-
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Related research
🔒 ★ 
🔒 IFPMA IDAP whitepaper: end-to-end access pathway for innovative medicines and vaccines
IDAP is a holistic framework spanning four linked phases: Research and Development; regulatory processes and product registration; listing, …
High impact 20 min
🔒 Integrated delivery networks in Middle East healthcare: what PwC says about the next phase of care
Scale creates value only when healthcare assets are connected through shared systems, referral flows and coordinated management disciplines
High impact 18 min
Frequently asked questions
What is vic-?
vic- is an FDA-listed pharmaceutical active ingredient.